Literature DB >> 25808006

Xenobiotic metabolizing enzymes in human skin and SkinEthic reconstructed human skin models.

Joan Eilstein1, Guillaume Léreaux1, Eric Arbey1, Edwige Daronnat1, Simon Wilkinson2, Daniel Duché1.   

Abstract

Skin metabolism is becoming a major consideration in the development of new cosmetic ingredients, skin being the first organ exposed to them. In order to replace limited samples of Excised human skin (EHS), in vitro engineered human skins have been developed. 3D models are daily used to develop and evaluate new cosmetic ingredients and have to be characterized and compared with EHS in terms of metabolic capabilities. This work presents the determination of apparent catalytic parameters (apparent Vmax, Km and the ratio Vmax/Km) in 3D models compared with EHS for cytochrome P450 dependent monooxygenase isoforms involved in drug metabolism, esterases, alcohol dehydrogenases, aldehyde dehydrogenases, peroxidases, glutathione S-transferases, N-acetyl transferases, uridinyl diphosphate glucuronyl transferases and sulfotransferases. Results show that all these enzymes involved in the metabolism of xenobiotics are expressed and functional in the EHS and 3D models. Also, the Vmax/Km ratios (estimating the intrinsic metabolic clearances) show that the metabolic abilities are the most often comparable between the skin models and EHS. These results indicate that the 3D models can substitute themselves for EHS to select cosmetic ingredients on the basis of their metabolism, efficacy or/and safety.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  extrahepatic organ; reconstructed human skin models; skin metabolism

Mesh:

Substances:

Year:  2015        PMID: 25808006     DOI: 10.1111/exd.12694

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  4 in total

Review 1.  Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; Robert Landsiedel
Journal:  Arch Toxicol       Date:  2018-06-18       Impact factor: 5.153

2.  Estimation of human percutaneous bioavailability for two novel brominated flame retardants, 2-ethylhexyl 2,3,4,5-tetrabromobenzoate (EH-TBB) and bis(2-ethylhexyl) tetrabromophthalate (BEH-TEBP).

Authors:  Gabriel A Knudsen; Michael F Hughes; J Michael Sanders; Samantha M Hall; Linda S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  2016-10-11       Impact factor: 4.219

3.  Safety assessment of cosmetics by read across applied to metabolomics data of in vitro skin and liver models.

Authors:  Carine Jacques; Emilien L Jamin; Isabelle Jouanin; Cécile Canlet; Marie Tremblay-Franco; Jean-François Martin; Daniel Zalko; Yves Brunel; Sandrine Bessou-Touya; Laurent Debrauwer; Pierre-Jacques Ferret; Hélène Duplan
Journal:  Arch Toxicol       Date:  2021-08-30       Impact factor: 5.153

Review 4.  Transdermal Permeation of Drugs in Various Animal Species.

Authors:  Hiroaki Todo
Journal:  Pharmaceutics       Date:  2017-09-06       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.